Activity and safety of pembrolizumab in patients with metastatic non-small cell lung cancer with untreated brain metastases

Authors :: Anne C. Chiang
Alexander O. Vortmeyer
Veronica Chiang
Elin Rowen
Xiaopan Yao
Heather Gerrish
Sarah B. Goldberg
Lucia B. Jilaveanu
Harriet M. Kluger
Matthew Madura
Stephanie Speaker
A. John Tsiouris
Roy S. Herbst
Scott N. Gettinger
Amit Mahajan
Elizabeth Knapp-Perry
Source :: Journal of Clinical Oncology. 33:8035-8035
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: 8035 Background: Brain metastases (BrMs) are common among patients (pts) with advanced non-small cell lung cancer (NSCLC) and local therapy such as surgery and radiation can add toxicity and delay ...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Pembrolizumab
medicine.disease
respiratory tract diseases
Internal medicine
Toxicity
Medicine
In patient
Non small cell
business
Lung cancer

Full Text Access

Tools